title: Stratifying a risk for an increased variation of airway caliber among the clinically stable asthma.
abstract: BACKGROUND
  Recently, correlations of peak expiratory flow (PEF) variation have been shown to facilitate the prediction of later asthma symptoms and exacerbations. However, it has not been fully examined whether or not any patient characteristics are associated with the residual airway lability in treated asthmatics. The objective of this study is to examine a predictive marker for increased variation of PEF in patients with clinically stable asthma.
  
  
  METHODS
  We studied 297 asthmatic patients who were monitored for PEF twice a day. Asthma Control Questionnaire (ACQ), spirometry, and exhaled nitric oxide fraction (FENO) were measured. After the assessment of baseline values, PEF measuring was continued and associations between these clinical markers and later variation of PEF over a week (Min%Max) were investigated.
  
  
  RESULTS
  17.5% of the subjects showed increased PEF variability (Min%Max < 80%). ACQ, forced expiratory volume in 1 s % of predicted (%FEV1), and FENO were identified as independent predictors of Min%Max < 80%. An ACQ ≥ 0.4 yielded 96% sensitivity and 59% specificity, a %FEV1 ≤ 85% yielded 62% sensitivity and 89% specificity, and a FENO ≥ 40 ppb yielded 75% sensitivity and 90% specificity for identifying the subjects with high variability in PEF. When we combine %FEV1 ≤ 85% and FENO ≥ 40 ppb, this index showed the highest specificity (98%) for increased PEF variability.
  
  
  CONCLUSIONS
  These results indicate that ACQ, %FEV1 and FENO can stratify the risk for increased variation in airway caliber among patients with stable asthma. This may help identify subjects in whom further monitoring of lung function fluctuations is indicated.
authors.affiliation: Third Department of Internal Medicine, Wakayama Medical University, School of Medicine, Wakayama, Japan.
authors.forename: Atsushi
authors.initials: A
authors.lastname: Hayata
authors.forename: Kazuto
authors.initials: K
authors.lastname: Matsunaga
authors.forename: Tsunahiko
authors.initials: T
authors.lastname: Hirano
authors.forename: Keiichiro
authors.initials: K
authors.lastname: Akamatsu
authors.forename: Tomohiro
authors.initials: T
authors.lastname: Ichikawa
authors.forename: Yoshiaki
authors.initials: Y
authors.lastname: Minakata
authors.forename: Masakazu
authors.initials: M
authors.lastname: Ichinose
mesh_terms: D000328:Adult; D000368:Aged; D001249:Asthma / Q000378:metabolism* / Q000473:pathology / Q000503:physiopathology*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009569:Nitric Oxide / Q000378:metabolism*; D015588:Observer Variation; D010366:Peak Expiratory Flow Rate; D012307:Risk Factors
chemical_list: D009569:Nitric Oxide